PB1706: ABL-CLASS GENOMIC BREAKPOINT Q-PCR FOR RELIABLE MEASURABLE RESIDUAL DISEASE MONITORING IN ALL PATIENTS

• Inge van Outersterp,
• Vincent van der Velden,
• Patricia Hoogeveen,
• Goda Vaitkevičienė,
• Gijs van Haaften,
• Roland Kuiper,
• Udo Zur Stadt,
• Judith M. Boer,
• Monique den Boer

Affiliations

Inge van Outersterp

1 Princess Máxima Center for Pediatric Oncology, Research, Utrecht, The Netherlands

Vincent van der Velden

2 Erasmus MC Cancer Institute, Department of Immunology, Rotterdam, The Netherlands

Patricia Hoogeveen

2 Erasmus MC Cancer Institute, Department of Immunology, Rotterdam, The Netherlands

Goda Vaitkevičienė

3 Vilnius university hospital Santaros klinikos, Center for Pediatric Oncology and Hematology, Vilnius, Lithuania

Gijs van Haaften

4 UMC Utrecht, Department of Genetics, Utrecht, The Netherlands

Roland Kuiper

1 Princess Máxima Center for Pediatric Oncology, Research, Utrecht, The Netherlands

Udo Zur Stadt

5 University Medical Center Hamburg-Eppendorf, Center for Diagnostics, Hamburg, Germany

Judith M. Boer

1 Princess Máxima Center for Pediatric Oncology, Research, Utrecht, The Netherlands

Monique den Boer

1 Princess Máxima Center for Pediatric Oncology, Research, Utrecht, The Netherlands